PT - JOURNAL ARTICLE AU - Honglv Xu AU - Min Yuan AU - Liya Ma AU - Meng Liu AU - Yi Zhang AU - Wenwen Liu AU - Hong Gan AU - Fangbiao Tao TI - Basic reproduction number of 2019 Novel Coronavirus Disease in Major Endemic Areas of China: A latent profile analysis AID - 10.1101/2020.04.13.20060228 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.13.20060228 4099 - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20060228.short 4100 - http://medrxiv.org/content/early/2020/04/17/2020.04.13.20060228.full AB - Objective The aim of the study is to analyze the latent class of basic reproduction number (R0) trend of 2019 novel coronavirus disease (COVID-19) in major endemic areas of China.Methods The provinces that reported more than 500 cases of COVID-19 till February 18, 2020 were selected as the major endemic area. The Verhulst model was used to fit the growth rate of cumulative confirmed cases. The R0 of COVID-19 was calculated using the parameters of severe acute respiratory syndrome (SARS) and COVID-19, respectively. The latent class of R0 was analyzed using a latent profile analysis model.Results The median R0 calculated from SARS and COVID-19 parameters were 1.84 - 3.18 and 1.74 - 2.91, respectively. The R0 calculated from the SARS parameters was greater than that of calculated from the COVID-19 parameters (Z = −4.782 - −4.623, P < 0.01). Both R0 can be divided into three latent classes. The initial value of R0 in class 1 (Shandong Province, Sichuan Province and Chongqing Municipality) was relatively low and decreases slowly. The initial value of R0 in class 2 (Anhui Province, Hunan Province, Jiangxi Province, Henan Province, Zhejiang Province, Guangdong Province and Jiangsu Province) was relatively high and decreases rapidly. Moreover, the initial value of R0 of class 3 (Hubei Province) was between that of class 1 and class 2, but the higher level of R0 lasts longer and decreases slowly.Conclusion The results indicated that overall trend of R0 has been falling with the strengthening of China’s comprehensive prevention and control measures for COVID-19, however, presents regional differences.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Anhui Medical University Emergency Key Research Project for Novel Coronavirus Pneumonia (YJGG202001) and Emergency Research Project, Anhui Provincial Department of Science and Technology, Anhui Provincial Health Commission (202004a07020002).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data has been shared in Mendeley Data. http://dx.doi.org/10.17632/48j3z3fxw6.2 http://dx.doi.org/10.17632/48j3z3fxw6.2